Altos Labs is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Altos Labs has hired top scientists with massive funding ($5B) to pursue cellular reprogramming, but the approach faces major hurdles: heterogeneous reprogramming in tissues, oncogene risks, delivery challenges, and unproven lifespan extension even in mice.